Anumana partners with Novartis for AI-driven heart disease detection
Anumana and Novartis Pharmaceuticals Corporation have partnered to use artificial intelligence (AI) for the detection of heart diseases.
Source: medicaldevice-network.com
Stay updated with breaking news from Early Detection Algorithm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anumana and Novartis Pharmaceuticals Corporation have partnered to use artificial intelligence (AI) for the detection of heart diseases.